{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:24:37Z","timestamp":1787851477738,"version":"build-2784847793"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Programa de Desarrollo de Ciencias B\u00e1sicas"},{"DOI":"10.13039\/501100006049","name":"Comisi\u00f3n Sectorial de Investigaci\u00f3n Cient\u00edfica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.physbeh.2017.07.016","type":"journal-article","created":{"date-parts":[[2017,7,10]],"date-time":"2017-07-10T14:32:58Z","timestamp":1499697178000},"page":"346-352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Clozapine blockade of MK-801-induced learning\/memory impairment in the mEPM: Role of 5-HT1A receptors and hippocampal BDNF levels"],"prefix":"10.1016","volume":"179","author":[{"given":"Ximena","family":"L\u00f3pez Hill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anal\u00eda","family":"Richeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Cecilia","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2017.07.016_bb0005","first-page":"31","article-title":"Cognitive function in schizophrenic patients","volume":"57","author":"Tollefson","year":"1996","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/oxfordjournals.schbul.a033430","article-title":"Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the \u201cright stuff\u201d?","volume":"26","author":"Green","year":"2000","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4088\/JCP.v65n0312","article-title":"Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness","volume":"65","author":"Harvey","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/oxfordjournals.schbul.a033363","article-title":"Neurocognitive and social functioning in schizophrenia","volume":"25","author":"Addington","year":"1999","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/appi.ajp.158.2.176","article-title":"Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment","volume":"158","author":"Harvey","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0030","first-page":"137","article-title":"Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol","volume":"26","author":"Purdon","year":"2001","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0035","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1176\/appi.ajp.159.6.1018","article-title":"Neurocognitive effects of colzapine, olanzapine, risperidone and haloperidol in patients with chronic schizophrenia or schizoaffective disorder","volume":"159","author":"Bilder","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0040","first-page":"140","article-title":"Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia","volume":"16","author":"Sumiyoshi","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0045","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1517\/13543784.2013.750650","article-title":"Assessing the prospect of donepezil in improving cognitive impairment in patients with schizophrenia","volume":"22","author":"Thakurathi","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(95)00242-D","article-title":"Effects of antipsychotics on cognitive behaviour in rats using the delayed non-match to position paradigm","volume":"281","author":"Didriksen","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF02245612","article-title":"Differential effect of antipsychotics on place navigation of rats in the Morris water maze","volume":"124","author":"Skarsfeldt","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejphar.2006.05.021","article-title":"Sertindole, in contrast to clozapine and olanzapine, does not disrupt water maze performance after acute or chronic treatment","volume":"542","author":"Didriksen","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0070","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1038\/sj.npp.1395370","article-title":"The role of serotonin in antipsychotic drug action","volume":"21","author":"Meltzer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0075","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1566-2772(03)00021-5","article-title":"Atypical antipsychotic drug actions: unitary or multiple mechanisms for atypicality","volume":"3","author":"Roth","year":"2003","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0080","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-011-2247-y","article-title":"Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties","volume":"216","author":"Newman-Tancredi","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0006-8993(91)90748-K","article-title":"Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain-a combined in situ hybridisation\/in vitro receptor autoradiographic study","volume":"561","author":"Chalmers","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0090","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1523\/JNEUROSCI.12-02-00440.1992","article-title":"Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor binding","volume":"12","author":"Pompeiano","year":"1992","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0095","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0014-2999(98)00483-X","article-title":"Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study","volume":"355","author":"Newman-Tancredi","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0100","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1176\/appi.ajp.158.10.1722","article-title":"Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment","volume":"158","author":"Sumiyoshi","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0105","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0006-3223(00)01025-8","article-title":"The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia","volume":"49","author":"Sumiyoshi","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0110","first-page":"802","article-title":"The importance of 5-HT1A receptor agonism in antipsychotic drug action: rationale and perspectives","volume":"11","author":"Newman-Tancredi","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnbeh.2013.00140","article-title":"Neural basis for the ability of atypical antipsychotic drugs to improve cognition in schizophrenia","volume":"7","author":"Sumiyoshi","year":"2013","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0120","series-title":"Society for Neuroscience-38th Annual Meeting","first-page":"155","article-title":"Distinctive affinity profile of novel antipsychotics possessing combined D2 and 5-HT1A receptor properties compared with conventional and atypical antipsychotics","volume":"9","author":"Cussac","year":"2008"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0125","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(97)81951-6","article-title":"Clozapine increases dopamine release in prefrontal cortex by 5-HT1A receptor activation","volume":"338","author":"Rollema","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0130","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","article-title":"5-HT2A and D2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release","volume":"76","author":"Ichikawa","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0135","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1471-4159.2005.03485.x","article-title":"The activation of 5-HT2A receptors in prefrontal cortex enhances dopaminergic activity","volume":"95","author":"Bortolozzi","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0140","doi-asserted-by":"crossref","first-page":"10831","DOI":"10.1523\/JNEUROSCI.2999-05.2005","article-title":"Involvement of 5-HT1A receptors in Prefrontal Cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action","volume":"25","author":"D\u00edaz-Mataix","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0145","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1017\/S146114571000009X","article-title":"Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT(1A) receptors but not 5-HT(2A) receptors","volume":"13","author":"Bortolozzi","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0150","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0022-3565(24)38019-X","article-title":"Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens","volume":"288","author":"Kuroki","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0160","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2008.08030368","article-title":"A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia","volume":"166","author":"Leucht","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0165","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/jpet.109.155663","article-title":"Differential effects of M1 and 5-HT1A receptors on atypical antipsychotics drug-induced dopamine efflux in the medial prefrontal cortex","volume":"330","author":"Li","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0170","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/npp.2011.249","article-title":"Phencyclidine-induced desynchronization of prefrontal cortex through a 5-HT(1A) receptor-dependent mechanism","volume":"37","author":"Kargieman","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0175","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2010.04.012","article-title":"Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801","volume":"59","author":"Scorza","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0180","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/hrp\/7.3.125","article-title":"NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders","volume":"7","author":"Krystal","year":"1999","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0190","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0269881113512909","article-title":"Reviewing the ketamine model for schizophrenia","volume":"28","author":"Frohlich","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbr.2006.07.003","article-title":"Phencyclidine affects memory in a nitric oxide-dependent manner: working and reference memory","volume":"174","author":"Wass","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0200","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00213-007-0774-3","article-title":"Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics","volume":"193","author":"Didriksen","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.physbeh.2015.05.013","article-title":"Measure of anxiety-related behaviors and hippocampal BDNF levels associated to the amnesic effect induced by MK-801 evaluated in the modified elevated plus-maze in rats","volume":"147","author":"Hill","year":"2015","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0006-8993(99)01422-5","article-title":"Effect of olanzapine on behavioural changes induced by FG 7142 and dizocilpine on active avoidance and plus maze tasks","volume":"830","author":"Ninan","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0215","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0166-4328(00)00298-9","article-title":"Oxiracetam prevents the MK-801 induced amnesia for the elevated plus-maze in mice","volume":"117","author":"Hlin\u00e1k","year":"2000","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000324523","article-title":"Effects of risperidone on learning and memory in naive and MK-801-treated rats","volume":"87","author":"Celikyurt","year":"2011","journal-title":"Pharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0225","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1254\/jphs.91.267","article-title":"Brain-derived neurotrophic factor\/TrkB signaling in memory processes","volume":"91","author":"Yamada","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/9780470751251.ch10","article-title":"Cell biology of BDNF and its relevance to schizophrenia","volume":"289","author":"Lu","year":"2008","journal-title":"Novartis Found. Symp."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0235","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.neuropharm.2013.04.024","article-title":"BDNF and memory processing","volume":"76","author":"Bekinschtein","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2011.09.022","article-title":"The role of BDNF in the pathophysiology and treatment of schizophrenia","volume":"46","author":"Favalli","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0166-4328(01)00347-3","article-title":"MK-801 induced amnesia for the elevated plus-maze in mice","volume":"131","author":"Hlin\u00e1k","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0250","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S1461145708008432","article-title":"Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapine","volume":"11","author":"Scorza","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0255","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.neuropharm.2012.01.025","article-title":"Role of the anterior thalamic nucleus in the motor hyperactivity induced by systemic MK-801 administration in rats","volume":"62","author":"L\u00f3pez Hill","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0260","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0014-2999(91)90125-A","article-title":"Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice","volume":"194","author":"Itoh","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0265","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0022-3565(24)35047-5","article-title":"Characterization of MK-801-induced behaviour as a putative rat model of psychosis","volume":"290","author":"Andine","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0270","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0166-4328(96)00118-0","article-title":"Electrophysiological, biochemical, neurohormonal and behavioral studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist","volume":"73","author":"Fletcher","year":"1996","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0275","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/nlme.1998.3886","article-title":"5-HT antagonists attenuate MK801-impaired radial arm maze performance in rats","volume":"71","author":"Boast","year":"1999","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0280","doi-asserted-by":"crossref","first-page":"8515","DOI":"10.1523\/JNEUROSCI.20-22-08515.2000","article-title":"Involvement of 5-HT1A receptors in classical fear conditioning in C57BL\/6J mice","volume":"20","author":"Stiedl","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0285","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejphar.2007.01.010","article-title":"The effects of 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) on food intake in non-deprived C57BL6 mice","volume":"559","author":"Ebenezer","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"5\u20136","key":"10.1016\/j.physbeh.2017.07.016_bb0290","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuropharm.2009.07.011","article-title":"Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities","volume":"57","author":"Youn","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0295","doi-asserted-by":"crossref","first-page":"809","DOI":"10.33549\/physiolres.930428","article-title":"N-Methyl-d-aspartate prevented memory deficits induced by MK-801 in mice","volume":"52","author":"Hlin\u00e1k","year":"2003","journal-title":"Physiol. Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0300","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.pnpbp.2003.09.003","article-title":"Animal behavior models of the mechanisms underlying antipsychotic atypicality","volume":"27","author":"Geyer","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0305","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(03)00757-8","article-title":"Bringing order to the glutamate chaos in schizophrenia","volume":"40","author":"Moghaddam","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.13582","article-title":"Dopamine d2 and serotonin 5-ht1a receptor interaction in the context of the effects of antipsychotics in vitro studies","author":"\u0141ukasiewicz","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0315","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(97)01234-X","article-title":"Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze","volume":"335","author":"Cao","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0320","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s002130050984","article-title":"Behavioural profiles in the mouse defence test battery suggest anxiolytic potential of 5-HT(1A) receptor antagonists","volume":"144","author":"Griebel","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0325","doi-asserted-by":"crossref","first-page":"74","DOI":"10.17305\/bjbms.2015.472","article-title":"Effect of clozapine on locomotor activity and anxietyrelated behavior in the neonatal mice administered MK-801","volume":"15","author":"P\u0131nar","year":"2015","journal-title":"Bosn J. Basic Med. Sci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0330","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pnpbp.2013.11.008","article-title":"Predictive validity of a MK-801-induced cognitive impairment model in mice: implications on the potential limitations and challenges of modeling cognitive impairment associated with schizophrenia preclinically","volume":"49","author":"Brown","year":"2014","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0335","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.brainresbull.2010.11.014","article-title":"The influence of N-desmethylclozapine and clozapine on recognition memory and BDNF expression in hippocampus","volume":"84","author":"Ertu\u011frul","year":"2011","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0340","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neulet.2011.07.004","article-title":"Effects of olanzapine and clozapine on memory acquisition, consolidation and retrieval in mice using the elevated plus maze test","volume":"501","author":"Mutlu","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0345","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0031-1291360","article-title":"Effects of olanzapine and clozapine on radial maze performance in naive and MK-801-treated mice","volume":"62","author":"Mutlu","year":"2012","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0350","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00213-002-1256-2","article-title":"Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study","volume":"166","author":"Chou","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0355","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nlm.2013.12.015","article-title":"Improving cognition in schizophrenia with antipsychotics that elicit neurogenesis through 5-HT1A receptor activation","volume":"110C","author":"Schreiber","year":"2014","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0360","doi-asserted-by":"crossref","first-page":"11496","DOI":"10.1523\/JNEUROSCI.2213-07.2007","article-title":"NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neuron","volume":"27","author":"Homayoun","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0365","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1073\/pnas.0704848104","article-title":"Antipsychotic drugs reverse the disruption in prefrontal cortex function produced by NMDA receptor blockade with phencyclidine","volume":"104","author":"Kargieman","year":"2007","journal-title":"PNAS"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0370","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jnr.10609","article-title":"Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-d-aspartate receptor activity","volume":"72","author":"Fumagalli","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0375","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1101\/lm.54603","article-title":"BDNF and activity-dependent synaptic modulation","volume":"10","author":"Lu","year":"2003","journal-title":"Learn. Mem."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0380","doi-asserted-by":"crossref","first-page":"61","DOI":"10.9758\/cpn.2012.10.2.61","article-title":"A review of brain-derived neurotrophic factor as a candidate biomarker in schizophrenia","volume":"10","author":"Nurjono","year":"2012","journal-title":"Clin. Psychopharmacol Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0385","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4103\/0253-7176.194913","article-title":"Brain-derived neurotrophic factor and suicide in schizophrenia: critical role of neuroprotective mechanisms as an emerging hypothesis","volume":"38","author":"Shrivastava","year":"2016","journal-title":"Indian J. Psychol. Med."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0390","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/jnr.10440","article-title":"Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs","volume":"71","author":"Bai","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0395","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1460-9568.2001.01633.x","article-title":"BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs","volume":"14","author":"Lipska","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0400","first-page":"2109","article-title":"Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK- 801","volume":"15","author":"Fumagalli","year":"2004","journal-title":"Mol. Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0405","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1177\/0269881112450780","article-title":"A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia","volume":"26","author":"Rizing","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0410","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.schres.2015.04.017","article-title":"Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: participation of antioxidant, nitrergic and neurotrophic mechanisms","volume":"165","author":"Vasconcelos","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0415","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/JMN:14:1-2:027","article-title":"Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents","volume":"14","author":"Linden","year":"2000","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0420","article-title":"Clozapine improves memory impairment and reduces A\u03b2 level in the Tg-APPswe\/PS1dE9 mouse model of Alzheimer's Disease","author":"Choi","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0425","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.lfs.2006.01.039","article-title":"Haloperidol and atypical antipsychotics share a same action of decreasing P75(NTR) mRNA levels in PC12 cells","volume":"79","author":"Bai","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0430","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pbb.2014.03.013","article-title":"Small-molecule TrkB agonist 7,8-dihydroxyflavone reverses cognitive and synaptic plasticity deficits in a rat model of schizophrenia","volume":"122","author":"Yang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0435","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","article-title":"Developments of a water-maze procedure for studying spatial learning in the rat","volume":"11","author":"Morris","year":"1984","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0440","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neuron.2009.11.031","article-title":"Are the dorsal and ventral hippocampus functionally distinct structures?","volume":"65","author":"Fanselow","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0445","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0028-3908(99)00031-3","article-title":"Selective modulation of fibroblast growth factor-2 expression in the rat brain by the atypical antipsychotic clozapine","volume":"38","author":"Riva","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.physbeh.2017.07.016_bb0450","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.0953-816x.2001.01459.x","article-title":"Fibroblast growth factor-2 is selectively modulated in the rat brain by E-5842, a preferential sigma-1 receptor ligand and putative atypical antipsychotic","volume":"13","author":"Ovalle","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0455","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/pcn.12242","article-title":"Psychopharmacology of atypical antipsychotic drugs: from the receptor binding profile to neuroprotection and neurogenesis","volume":"69","author":"Kusumi","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.physbeh.2017.07.016_bb0460","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","article-title":"Akt\/gsk3 signaling in the action of psychotropic drugs","volume":"49","author":"Beaulieu","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938417302160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938417302160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:03:10Z","timestamp":1758477790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938417302160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":92,"alternative-id":["S0031938417302160"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2017.07.016","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clozapine blockade of MK-801-induced learning\/memory impairment in the mEPM: Role of 5-HT1A receptors and hippocampal BDNF levels","name":"articletitle","label":"Article Title"},{"value":"Physiology & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.physbeh.2017.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}